Trial Profile
A Rapamune Follow-Up Registry in Transplant Recipients in the Nordic Countries, 'Wrap-Up'.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2012
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 30 Jan 2012 Actual patient number (66) added as reported by ClinicalTrials.gov.
- 13 Oct 2010 Actual end date (June 2008) added as reported by ClinicalTrials.gov.
- 13 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.